Following this transaction MORRIS JESSICA EDGAR’s holding in the company was increased by 22.42% to a total of $6,716. In addition to MORRIS JESSICA EDGAR, 4 other TNXP executives reported Buy trades in the last month.
Currently, Tonix Pharma has an average volume of 121.2K.
Four different firms, including B.Riley FBR and Cantor Fitzgerald, currently also have a Buy rating on the stock.
The insider sentiment on Tonix Pharma has been positive according to 11 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.